Currently, there are 102.94M common shares owned by the public and among those 100.24M shares have been available to trade.
The company’s stock has a 5-day price change of 11.32% and 56.76% over the past three months. EVGO shares are trading 81.28% year to date (YTD), with the 12-month market performance up to 114.19% higher. It has a 12-month low price of $1.65 and touched a high of $9.07 over the same period. EVGO has an average intraday trading volume of 8.36 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 3.12%, 1.86%, and 76.10% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of EVgo Inc (NASDAQ: EVGO) shares accounts for 52.86% of the company’s 102.94M shares outstanding.
It has a market capitalization of $1.97B and a beta (3y monthly) value of 2.28. The earnings-per-share (ttm) stands at -$0.42. Price movements for the stock have been influenced by the stock’s volatility, which stands at 7.99% over the week and 10.50% over the month.
Earnings per share for the fiscal year are expected to increase by 11.13%, and 21.73% over the next financial year.
Looking at the support for the EVGO, a number of firms have released research notes about the stock. UBS stated their Buy rating for the stock in a research note on October 10, 2024, with the firm’s price target at $4-$8.50. TD Cowen coverage for the EVgo Inc (EVGO) stock in a research note released on October 03, 2024 offered a Buy rating with a price target of $7. JP Morgan was of a view on October 03, 2024 that the stock is Overweight, while UBS gave the stock Neutral rating on July 22, 2024, issuing a price target of $4. The Benchmark Company on their part issued Buy rating on June 05, 2024.
